68 related articles for article (PubMed ID: 38728523)
1. Evidence Construction of Chuankezhi Injection Against Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Pharmacology.
Wei X; Zhong Y; Yi X; Li T; Ling Z; Ming M; Zhang S; He Z
Int J Chron Obstruct Pulmon Dis; 2024; 19():1177-1196. PubMed ID: 38826697
[TBL] [Abstract][Full Text] [Related]
2. Screening study on significant Chinese herb for anti-idiopathic pulmonary fibrosis by combining clinical experience prescriptions and molecular dynamics simulation technologies.
Yan H; He B; He L; Ye H
J Biomol Struct Dyn; 2024 Aug; 42(12):6393-6409. PubMed ID: 37963492
[TBL] [Abstract][Full Text] [Related]
3. Endotype-driven Co-module mechanisms of danhong injection in the Co-treatment of cardiovascular and cerebrovascular diseases: A modular-based drug and disease integrated analysis.
Zhang S; Niu Q; Zong W; Song Q; Tian S; Wang J; Liu J; Zhang H; Wang Z; Li B
J Ethnopharmacol; 2024 Sep; 331():118287. PubMed ID: 38705429
[TBL] [Abstract][Full Text] [Related]
4. Exploring the efficacy and molecular mechanism of Danhong injection comprehensively in the treatment of idiopathic pulmonary fibrosis by combining meta-analysis, network pharmacology, and molecular docking methods.
Wu X; Li W; Luo Z; Chen Y
Medicine (Baltimore); 2024 May; 103(19):e38133. PubMed ID: 38728523
[TBL] [Abstract][Full Text] [Related]
5. The molecular mechanism of Ligusticum wallichii for improving idiopathic pulmonary fibrosis: A network pharmacology and molecular docking study.
Wu X; Li W; Luo Z; Chen Y
Medicine (Baltimore); 2022 Feb; 101(6):e28787. PubMed ID: 35147109
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of Danhong injection for idiopathic pulmonary fibrosis：Meta-analysis].
Xin LL; Jiang M; Zhang G; Gong JN
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3859-3865. PubMed ID: 28929667
[TBL] [Abstract][Full Text] [Related]
7. Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients.
Yan L; Jiang MY; Fan XS
J Ethnopharmacol; 2023 Dec; 317():116773. PubMed ID: 37308028
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 4 kinds of traditional Chinese medicine injections to assist in improving clinical indicators of patients with idiopathic pulmonary fibrosis: A systematic review and network meta-analysis.
Wu X; Li W; Qin Z; Luo Z; Xue L; Chen Y
Medicine (Baltimore); 2022 Nov; 101(47):e31877. PubMed ID: 36451506
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review.
Hou Y; Wang G; Han S; Liu H; Jia X
Medicine (Baltimore); 2023 Jun; 102(22):e33729. PubMed ID: 37266620
[TBL] [Abstract][Full Text] [Related]
10. Unfolded protein response pathways in stroke patients: a comprehensive landscape assessed through machine learning algorithms and experimental verification.
Yu H; Ji X; Ouyang Y
J Transl Med; 2023 Oct; 21(1):759. PubMed ID: 37891634
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cyclooxygenase-2 fluctuation via a near-infrared fluorescent probe in idiopathic pulmonary fibrosis cell and mice models.
Wang Y; Wei Y; He N; Zhang L; You J; Chen L; Lv C
J Mater Chem B; 2021 Aug; 9(31):6226-6233. PubMed ID: 34320042
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappa B and its role in inflammatory lung disease.
Alharbi KS; Fuloria NK; Fuloria S; Rahman SB; Al-Malki WH; Javed Shaikh MA; Thangavelu L; Singh SK; Rama Raju Allam VS; Jha NK; Chellappan DK; Dua K; Gupta G
Chem Biol Interact; 2021 Aug; 345():109568. PubMed ID: 34181887
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study.
Xie B; Ren Y; Geng J; He X; Ban C; Wang S; Jiang D; Luo S; Chen Q; Liu M; Feng R; Zhao L; Dai H; Wang C
BMJ Open; 2020 Nov; 10(11):e036809. PubMed ID: 33177132
[TBL] [Abstract][Full Text] [Related]
14. Natural Product Inhibitors of Cyclooxygenase (COX) Enzyme: A Review on Current Status and Future Perspectives.
Ambati GG; Jachak SM
Curr Med Chem; 2021; 28(10):1877-1905. PubMed ID: 32484764
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs and nuclear architecture during epithelial-mesenchymal transition in lung cancer and idiopathic pulmonary fibrosis.
Rubio K; Castillo-Negrete R; Barreto G
Cell Signal; 2020 Jun; 70():109593. PubMed ID: 32135188
[TBL] [Abstract][Full Text] [Related]
16. Kaempferol Modulates Autophagy and Alleviates Silica-Induced Pulmonary Fibrosis.
Liu H; Yu H; Cao Z; Gu J; Pei L; Jia M; Su M
DNA Cell Biol; 2019 Dec; 38(12):1418-1426. PubMed ID: 31560574
[TBL] [Abstract][Full Text] [Related]
17. Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis.
Hill C; Li J; Liu D; Conforti F; Brereton CJ; Yao L; Zhou Y; Alzetani A; Chee SJ; Marshall BG; Fletcher SV; Hancock D; Ottensmeier CH; Steele AJ; Downward J; Richeldi L; Lu X; Davies DE; Jones MG; Wang Y
Cell Death Dis; 2019 Aug; 10(8):591. PubMed ID: 31391462
[TBL] [Abstract][Full Text] [Related]
18. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.
Kheirollahi V; Wasnick RM; Biasin V; Vazquez-Armendariz AI; Chu X; Moiseenko A; Weiss A; Wilhelm J; Zhang JS; Kwapiszewska G; Herold S; Schermuly RT; Mari B; Li X; Seeger W; Günther A; Bellusci S; El Agha E
Nat Commun; 2019 Jul; 10(1):2987. PubMed ID: 31278260
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
